Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Mar;13(1):130-42.
doi: 10.1007/s11938-014-0044-5.

Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?

Edith Y Ho  1 , Fabio Cominelli, Jeffry Katz
Affiliations

Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?

Edith Y Ho et al. Curr Treat Options Gastroenterol. 2015 Mar.

Abstract

The treatment paradigms and therapeutic options for ulcerative colitis (UC) have rapidly evolved during the past decade. Traditionally, the treatment target has focused on achieving successful induction and maintenance of steroid-free clinical remission. This has been shown to provide a better quality of life and a reduction in complications, hospitalizations, and surgery. Recent studies, however, suggest that achieving "mucosal healing" or endoscopic remission may be the optimal treatment endpoint. In this review, we will examine the treatment goals for UC and the efficacy of each therapy to reach these targets. We will also review the therapeutic options available for UC: mesalamines, steroids, immunomodulators, and biologics, including the first anti-integrin inhibitor, approved in May 2014, for the treatment of UC. Therapeutic drug monitoring, which measures serum drug level and anti-drug antibody concentrations, is emerging as an important clinical decision tool in patients on tumor necrosis factor (TNF)-antagonists. These evolving treatment strategies allow gastroenterologists to optimize control of the disease and offer patients a better quality of life.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Lancet. 2012 Dec 1;380(9857):1909-15 - PubMed
    1. Gut. 2014 Mar;63(3):433-41 - PubMed
    1. Gastroenterology. 2013 Nov;145(5):987-95 - PubMed
    1. Gastroenterology. 2014 Feb;146(2):392-400.e3 - PubMed
    1. Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524 - PubMed

LinkOut - more resources